American Institute for Cancer Research

Pazazz® Apple and America's Test Kitchen's Chef Elle Simone Scott Partner During National Cancer Prevention Month to Share Healthy Eating Tips

Retrieved on: 
Wednesday, February 1, 2023

Chef Elle is spreading the word about the health benefits of eating apples, including their anti-cancer properties and ability to boost mood.

Key Points: 
  • Chef Elle is spreading the word about the health benefits of eating apples, including their anti-cancer properties and ability to boost mood.
  • Catch her Instagram Live with Chef Evey Williams (@simply_ok) as they talk healthy eating.
  • In addition to being a celebrity chef and America's Test Kitchen food stylist, Chef Elle is also a cancer survivor and Ovarian Cancer Research Alliance board member.
  • Chef Elle's Pazazz apple recipes make eating them both delicious and fun," said Kristi Harris, Honeybear Brands Brand Manager.

Global Monoclonal Antibodies Market Report 2022: Cost-effective Advanced Technology for Developing mABs Presents Billion-Dollar Opportunity - ResearchAndMarkets.com

Retrieved on: 
Friday, August 26, 2022

The "Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Source, Production Method, Indication, Application, and End-User" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Source, Production Method, Indication, Application, and End-User" report has been added to ResearchAndMarkets.com's offering.
  • The monoclonal antibodies market is segmented on the basis of source, production method, indication application, and end-user.
  • By indication, the monoclonal antibodies market is segmented into cancer, autoimmune diseases, inflammatory diseases, infectious disease, microbial disease, and others.
  • The hospital segment holds the largest market share owing to the increasing adoption mABs as a preferred line of treatment against cancer.

Global High Intensity Focused Ultrasound Market (2022 to 2027) - Featuring Hitachi, General Electric and Medtronic Among Others - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 16, 2022

Besides, focused ultrasound surgery (FUS) is a non-invasive technique that can ablate tumor lesions precisely when combined with high-intensity imaging methods.

Key Points: 
  • Besides, focused ultrasound surgery (FUS) is a non-invasive technique that can ablate tumor lesions precisely when combined with high-intensity imaging methods.
  • As the COVID-19 pandemic progresses, the High-intensity focused ultrasound (HIFU) therapy industry has seen a growth drop.
  • Worldwide High-intensity Focused Ultrasound (HIFU) Therapy Market Size was US$ 269.3 Million in 2021:
    Based on modality, the High-Intensity Focused Ultrasound Therapy market is segmented into therapeutic ultrasound, hemostasis, others.
  • Major players operating in the HIFU therapy industry include Johnson & Johnson, Hitachi, Ltd, General Electric, Medtronic, Inc., Stryker, Koninklijke Philips, EDAP TMS S.A, Supersonic Imagine.

New Study Finds AICR/WCRF’s Cancer Prevention Recommendations Are Associated With Reduced Mortality Risk From All Causes, Cancer, And Heart Disease

Retrieved on: 
Tuesday, July 5, 2022

They found that following a lifestyle aligned with the 2018 WCRF/AICR Cancer Prevention Recommendations was associated with a significant reduction in risk of all-cause, cancer-specific and cardiovascular-specific mortality.

Key Points: 
  • They found that following a lifestyle aligned with the 2018 WCRF/AICR Cancer Prevention Recommendations was associated with a significant reduction in risk of all-cause, cancer-specific and cardiovascular-specific mortality.
  • This study found that each one-point increase in the 2018 WCRF/AICR Score was associated with a 9-26% reduced mortality risk, except in current male smokers cancer mortality risk; the strongest associations were seen in former smokers.
  • These results underline the importance of following the AICRs 10 Cancer Prevention Recommendations to reduce cancer risk and mortality.
  • Find evidence-based tools and information for lowering cancer risk, including AICRs Cancer Prevention Recommendations, at aicr.org .

Gastric Cancer Drugs Global Market Research Report 2022: Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 30, 2022

The "Gastric Cancer Drugs Global Market Report 2022, Type, End User, Route of Administration" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Gastric Cancer Drugs Global Market Report 2022, Type, End User, Route of Administration" report has been added to ResearchAndMarkets.com's offering.
  • The gastric cancer drugs market consists of sales of drugs for gastric cancer.
  • The main types of gastric cancer drugs are doxorubicin hydrochloride, sunitinib, docetaxel, mitomycin, fluorouracil, imatinib and trastuzumab.
  • Increase in number of cases in gastric cancer will drive the market for gastric cancer drugs.

Sit Less, Move More: New Studies Show Physical Activity Can Significantly Improve Quality Of Life After Colorectal Cancer

Retrieved on: 
Thursday, June 2, 2022

According to National Cancer Institute, one is considered a cancer survivor from the time of diagnosis, through the balance of his or her life.

Key Points: 
  • According to National Cancer Institute, one is considered a cancer survivor from the time of diagnosis, through the balance of his or her life.
  • American Institute for Cancer Research (AICR) funds studies to investigate the impact of lifestyle factors on the entire cancer spectrum, from prevention to treatment to survivorship.
  • Recently, two new studies funded by American Institute for Cancer Research (AICR) and World Cancer Research Fund (WCRF) found that reducing sedentary behavior and increasing physical activity has a positive impact on the quality of life for colorectal cancer survivors.
  • This could potentially explain the health-enhancing effects of physical activity in colorectal cancer survivors and support its future integration into post-treatment care in this population.

Global Proleukin Market Report to 2027 - Players Include Chiron and Prometheus Laboratories - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 31, 2022

The global proleukin market is anticipated to grow at a considerable CAGR during the forecast period.

Key Points: 
  • The global proleukin market is anticipated to grow at a considerable CAGR during the forecast period.
  • Some of the companies operating in the global proleukin market include Chiron Corp., Prometheus Laboratories, and others.
  • Analysis of regional regulations and other government policies impacting the global proleukin market.
  • Insights about market determinants that are stimulating the global proleukin market.

Global Photoacoustic Tomography Market Forecast to 2028 - COVID-19 Impact and Analysis - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 31, 2022

The "Photoacoustic Tomography Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Geometry, Type, Application and End User" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Photoacoustic Tomography Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Geometry, Type, Application and End User" report has been added to ResearchAndMarkets.com's offering.
  • The photoacoustic tomography market is projected to reach US$ 209.56 million by 2028 from US$ 61.12 million in 2021; it is expected to grow at a CAGR of 19.2% from 2021 to 2028.
  • Therefore, the accuracy of photoacoustic tomography in the detection of cancer tissues, in addition to the increase in the prevalence of cancer, is driving the growth of the photoacoustic tomography market.
  • On the basis of type, the photoacoustic tomography market is divided into intravascular photoacoustic tomography,photoacoustic microscopy, and others.

Annual "Shred Cancer" Event to Raise $50,000 for Cancer Prevention Research

Retrieved on: 
Thursday, May 19, 2022

STERLING, Va., May 19, 2022 /PRNewswire-PRWeb/ -- PROSHRED® Security (PROSHRED®) will be celebrating the ninth anniversary of their annual nationwide "Shred Cancer" Event. The first of the events will take place on Saturday, June 4, 2022, and will continue through to the end of August 2022 in partnership with The American Institute for Cancer Research (AICR). Community members are invited to bring their personal information to be securely shredded while raising funds for cancer research.

Key Points: 
  • STERLING, Va., May 19, 2022 /PRNewswire-PRWeb/ -- PROSHRED Security (PROSHRED) will be celebrating the ninth anniversary of their annual nationwide "Shred Cancer" Event.
  • Community members are invited to bring their personal information to be securely shredded while raising funds for cancer research.
  • Commencing in 2014 on National Cancer Survivors' Day, PROSHRED has contributed over $190,000 to cancer research.
  • Find evidence-based tools and information for lowering cancer risk, including AICR's Recommendation for Cancer Prevention, at http://www.aicr.org .

Global Breast Imaging Devices Market Growth Forecasts Report 2022, Featuring Siemens Healthcare, GE Healthcare, Hologic and Aurora Imaging Technology - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 17, 2022

Asia Pacific was the second largest market in breast imaging devices market.

Key Points: 
  • Asia Pacific was the second largest market in breast imaging devices market.
  • The rising prevalence of breast cancer is anticipated to contribute to the breast imaging devices market's growth.
  • It places the market within the context of the wider breast imaging devices market, and compares it with other markets.
  • It compares the breast imaging devices market with other segments of the breast imaging devices market by size and growth, historic and forecast.